Instrument Inactif

Communiqués IMARA

Actions

IMRA

US45249V1070

Communiqués

22/02/23	IMARA INC. : Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22/02/23	Imara Announces Stockholder Approval of Merger With Enliven	GL
22/02/23	Imara Announces Stockholder Approval of Merger With Enliven	GL
13/02/23	IMARA INC. : Other Events (form 8-K)	AQ
10/02/23	IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
25/01/23	IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA	BU
05/12/22	IMARA INC. : Other Events (form 8-K)	AQ
16/11/22	IMARA INC. Financial Statements and Exhibits (form 8-K/A)	AQ
10/11/22	IMARA INC. : Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
25/10/22	IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
15/10/22	IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA	BU
14/10/22	IMARA INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
13/10/22	IMARA INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
13/10/22	Enliven Therapeutics and Imara Announce Merger Agreement	GL
07/09/22	IMARA INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
03/08/22	IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
29/07/22	IMARA INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
03/06/22	IMARA INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
06/05/22	IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
14/04/22	IMARA INC. : Costs Associated with Exit or Disposal Activities (form 8-K)	AQ
05/04/22	Imara Announces Results of Interim Analyses of Tovinontrine (IMR-687) Phase 2b Clinical Trials in Sickle Cell Disease and Beta-Thalassemia	AQ
15/03/22	IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
15/03/22	Imara : Reports Full Year 2021 Financial Results and Business Highlights - Form 8-K	PU
15/03/22	Imara Reports Full Year 2021 Financial Results and Business Highlights	GL
15/03/22	Imara Reports Full Year 2021 Financial Results and Business Highlights	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Communiqués IMARA

Actions

IMRA

US45249V1070

Communiqués

Filtres